Company · CIK 1906324

# QuidelOrtho Corp

| CIK | [1906324](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001906324) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Business address | CA |
| Listed | QDEL (Nasdaq) |
| First annual or quarterly report | 2022-08-05 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-283339 | Shelf Effective | 2024-11-19 | 2024-11-19 | 1 |

## Filings

 2

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2024-11-19 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1906324/000119312524261741/0001193125-24-261741-index.htm) Shelf registered | 333-283339 | 0001193125-24-261741 |
| 2022-04-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1906324/999999999522000922/9999999995-22-000922-index.htm) Declared effective | 333-262434 | 9999999995-22-000922 |

[All filings of this company](https://equitycapital.markets/filings?cik=1906324) · [CSV](https://equitycapital.markets/filings.csv?cik=1906324)

---
Source page: https://equitycapital.markets/company/1906324 · Data: U.S. SEC EDGAR · CC BY 4.0